...
首页> 外文期刊>Emerging Infectious Diseases >Drug-Resistant Tuberculosis among Children, China, 2006–2015
【24h】

Drug-Resistant Tuberculosis among Children, China, 2006–2015

机译:2006-2015年中国儿童抗药性肺结核

获取原文
           

摘要

Microbial drug resistance has become a major public health concern worldwide. To acquire epidemiologic data on drug-resistant tuberculosis (DR TB) among children, a major cause of illness and death for this population, we conducted a retrospective study of 2006–2015 data from 36 TB prevention and control institutions in Shandong Province, China. A total of 14,223 new TB cases, among which children ( < 18 years of age) accounted for only 5.5%, were caused by culture-confirmed Mycobacterium tuberculosis . Among children with TB, 18.9% had DR TB and 6.9% had multidrug-resistant TB. Over the past decade, the percentage of DR TB; multidrug-resistant TB; and overall first-line drug resistance for isoniazid, rifampin, ethambutol, and streptomycin among children increased significantly (at least 12%). Understanding the long-term trends of DR TB among children can shed light on the performance of TB control programs, thereby contributing to global TB control.
机译:微生物耐药性已成为全球主要的公共卫生问题。为了获得儿童中耐药结核病(DR TB)的流行病学数据,这是该人群疾病和死亡的主要原因,我们对中国山东省的36 TB预防和控制机构进行了2006-2015年数据的回顾性研究。由培养证实的结核分枝杆菌引起的总共14,223例新结核病例,其中儿童(<18岁)仅占5.5%。在结核病儿童中,有18.9%患有DR结核病,而6.9%患有耐多药结核病。在过去十年中,DR TB的百分比;耐多药结核病;儿童中异烟肼,利福平,乙胺丁醇和链霉素的整体一线耐药性显着增加(至少12%)。了解儿童中DR TB的长期趋势可以阐明TB控制计划的绩效,从而有助于全球TB控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号